Provided by Tiger Trade Technology Pte. Ltd.

Immunome Inc.

20.89
-0.6200-2.88%
Post-market: 20.890.00000.00%19:30 EDT
Volume:1.10M
Turnover:23.01M
Market Cap:2.37B
PE:-8.41
High:21.49
Open:21.17
Low:20.71
Close:21.51
52wk High:30.06
52wk Low:11.25
Shares:113.58M
Float Shares:108.11M
Volume Ratio:0.66
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4851
EPS(LYR):-2.4315
ROE:-64.03%
ROA:-37.78%
PB:4.52
PE(LYR):-8.59

Loading ...

US Stocks on the MOVE-Cardinal Health, nVent, Acuity

Reuters
·
5 hours ago

Immunome Climbs as Stifel Initiates Coverage

Reuters
·
Yesterday

Immunome Price Target Announced at $24.00/Share by Stifel

Dow Jones
·
Yesterday

Immunome, Inc. : Stifel Initiates Coverage with Hold Rating; Price Target $24

THOMSON REUTERS
·
Yesterday

Stifel Initiates Immunome at Hold With $24 Price Target

MT Newswires Live
·
Yesterday

Barclays Remains a Buy on Immunome (IMNM)

TIPRANKS
·
Yesterday

Immunome initiated with a Hold at Stifel

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA) and Immunome (IMNM)

TIPRANKS
·
Sep 30

Immunome announces IND clearance for IM-1340 in solid tumors

TIPRANKS
·
Sep 30

Immunome Says FDA Clears IND for IM-1340 Solid Tumor ADC

Reuters
·
Sep 30

Immunome, - to Initiate Phase 1 Study of IM-1340 in Q4 2026

THOMSON REUTERS
·
Sep 30

Immunome Announces Ind Clearance for IM-1340, a Potential First-in-Class Antibody-Drug Conjugate for the Treatment of Solid Tumors

THOMSON REUTERS
·
Sep 30

Immunome initiated with a Buy at Alliance Global

TIPRANKS
·
Sep 21

Immunome, Inc. : Alliance Global Partners Initiates Coverage with Buy Rating; Target Price $32

THOMSON REUTERS
·
Sep 21

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)

TIPRANKS
·
Sep 10

Immunome Price Target Maintained with a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 10

Immunome Grants 86,500 Inducement Stock Options at $27.07 Per Share

Reuters
·
Sep 09

Immunome Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 09

Immunome to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 02

Argenx's Myositis Data Strengthen Efgartigimod Outlook, Morgan Stanley Says

MT Newswires Live
·
Aug 18